XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   42,390,586      
Beginning balance at Dec. 31, 2022 $ 176,157 $ 5 $ 396,041 $ (877) $ (219,012)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)   11,888      
Exercise of stock options and purchases pursuant to employee stock purchase plan 39   39    
Issuance of common stock upon settlement of restricted stock units (in shares)   73,937      
Shares withheld related to net share settlement (in shares)   (16,153)      
Shares withheld related to net share settlement (39)   (39)    
Stock-based compensation expense 1,683   1,683    
Unrealized gain (loss) on investments 538     538  
Net loss (20,724)       (20,724)
Ending balance (in shares) at Mar. 31, 2023   42,460,258      
Ending balance at Mar. 31, 2023 157,654 $ 5 397,724 (339) (239,736)
Beginning balance (in shares) at Dec. 31, 2022   42,390,586      
Beginning balance at Dec. 31, 2022 176,157 $ 5 396,041 (877) (219,012)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized gain (loss) on investments 803        
Net loss (42,070)        
Ending balance (in shares) at Jun. 30, 2023   42,471,335      
Ending balance at Jun. 30, 2023 138,458 $ 5 399,609 (74) (261,082)
Beginning balance (in shares) at Mar. 31, 2023   42,460,258      
Beginning balance at Mar. 31, 2023 157,654 $ 5 397,724 (339) (239,736)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)   11,077      
Exercise of stock options and purchases pursuant to employee stock purchase plan 33   33    
Stock-based compensation expense 1,852   1,852    
Unrealized gain (loss) on investments 265     265  
Net loss (21,346)       (21,346)
Ending balance (in shares) at Jun. 30, 2023   42,471,335      
Ending balance at Jun. 30, 2023 138,458 $ 5 399,609 (74) (261,082)
Beginning balance (in shares) at Dec. 31, 2023   47,260,108      
Beginning balance at Dec. 31, 2023 144,705 $ 5 451,006 4 (306,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)   145,841      
Exercise of stock options and purchases pursuant to employee stock purchase plan 609   609    
Issuance of common stock upon settlement of restricted stock units (in shares)   156,803      
Shares withheld related to net share settlement (in shares)   (43,533)      
Shares withheld related to net share settlement (437)   (437)    
Stock-based compensation expense 2,475   2,475    
Proceeds from sale of common stock (17)   (17)    
Unrealized gain (loss) on investments (18)     (18)  
Net loss (18,504)       (18,504)
Ending balance (in shares) at Mar. 31, 2024   47,519,219      
Ending balance at Mar. 31, 2024 128,813 $ 5 453,636 (14) (324,814)
Beginning balance (in shares) at Dec. 31, 2023   47,260,108      
Beginning balance at Dec. 31, 2023 144,705 $ 5 451,006 4 (306,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized gain (loss) on investments (9)        
Net loss (40,056)        
Ending balance (in shares) at Jun. 30, 2024   47,727,269      
Ending balance at Jun. 30, 2024 110,616 $ 5 456,982 (5) (346,366)
Beginning balance (in shares) at Mar. 31, 2024   47,519,219      
Beginning balance at Mar. 31, 2024 128,813 $ 5 453,636 (14) (324,814)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)   205,042      
Exercise of stock options and purchases pursuant to employee stock purchase plan 691   691    
Issuance of common stock upon settlement of restricted stock units (in shares)   3,975      
Shares withheld related to net share settlement (in shares)   (967)      
Shares withheld related to net share settlement (10)   (10)    
Stock-based compensation expense 2,665   2,665    
Unrealized gain (loss) on investments 9     9  
Net loss (21,552)       (21,552)
Ending balance (in shares) at Jun. 30, 2024   47,727,269      
Ending balance at Jun. 30, 2024 $ 110,616 $ 5 $ 456,982 $ (5) $ (346,366)